IMMUTEP LIMITED - AMERICAN DEPOSITARY SHARES
2.0100
10-January-25 15:45:00
15 minutes delayed
Stocks
+0.0100
+0.50%
Today's range
1.9300 - 2.0500
ISIN
N/A
Source
NASDAQ
-
03 Nov 2023 11:00:00 By Nasdaq GlobeNewswire
-
Immutep to Participate in November Investor Events
02 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q1 FY24
31 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep receives ~A$1.13 million R&D Tax Incentive
25 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
24 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep Announces Publication of Abstracts at ESMO Congress 2023
16 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
21 Sep 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep to Participate in September Investor Conferences
05 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Immutep Receives Positive Scientific Advice from European Medicines Agency
01 Aug 2023 07:00:02 By Nasdaq GlobeNewswire
-
31 Jul 2023 07:00:01 By Nasdaq GlobeNewswire
-
Immutep Quarterly Activities Report Q4 FY23
31 Jul 2023 07:00:01 By Nasdaq GlobeNewswire
-
28 Jul 2023 07:00:00 By Nasdaq GlobeNewswire
-
Immutep Completes A$80 Million Capital Raise
27 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
27 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Immutep Granted United States Patent for IMP761, a First-in-Class Agonist Antibody Targeting LAG-3
20 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Immutep to Participate at the Jefferies Healthcare Conference
07 Jun 2023 07:00:00 By Nasdaq GlobeNewswire
-
05 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
02 Jun 2023 07:00:00 By Nasdaq GlobeNewswire